Injection snoreplasty: How to treat snoring without all the pain and expense

OBJECTIVE: We introduce Injection Snoreplasty: an innovative, safe, and eff ective palatal snoring procedure with minimal cost and discomfort to the pa tient, A well-described sclerotherapy agent, Sotradecol, is injected into t he soft palate to reduce/eliminate palatal flutter snoring. STUDY DESIGN AND SETTING: Twenty-seven patients with a diagnosis of palatal flutter snoring (respiratory disturbance index less than In) by sleep stud y were enrolled in the protocol, Office treatment sessions were performed 6 to 8 weeks apart, Success was judged by subjective improvement in snoring and objective evidence of palatal stiffening/scarring RESULTS: Twenty-five (92%) of 27 patients reported significant decrease in snoring, There were no significant postinjection complications. Visual anal og pain scale confirmed minimal discomfort. Most patients received more tha n I treatment (average, 1.8) In order to receive optimal palatal stiffening , CONCLUSION/SIGNIFICANCE: Injection Snoreplasty is a simple, safe, and effec tive office treatment for primary snoring, Advantages over current snoring procedures include simplicity, low cost, decreased posttreatment pain level s, and minimal/no convalescence.